|Day Low/High||152.83 / 158.25|
|52 Wk Low/High||112.60 / 172.18|
Expect more fiscal and monetary support and don't expect a full return to previous economic activity for quite some time.
I recently endorsed the packaged foods goods sector and have purchased more Kraft Heinz , TreeHouse Foods and J. M. Smucker . (All three are on my Best Ideas List.) The stocks did quite well yesterday. Credit Suisse chimed in bullishly this morning ...
I don't think any of the takeaways have to do with the political mess in Iowa, nor the 'State of the Union' address scheduled for Tuesday night.
These stocks are priced for total imperfection. That's just what you want.
Markets are watching what Fed Chair Powell will signal for future rate cuts during this afternoon's FOMC rate decision.
Traders need to respect this price strength.
So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.
Understand that the expected Fed rate cut today is not about recent economic performance in the least.
We have more than 1,050 companies reporting quarterly earnings from Monday to Friday, and here are the ones to keep focus on.
As usual, the stocks that bounce back first are the tech stocks with little Chinese exposure and the consumer packaged goods that just demonstrated good numbers.
I've spotlighted three blue-chip companies with stock prices that are at ridiculously low valuations right now.
Cardinal Health and McKesson have similar business models, but they are very different stocks.
Undervalued shares can get even cheaper in the short run but eventually they play catch up, running much higher.
Many see the Fed as done for the year. Never assume. Read the words as they are written.
McKesson is a high-quality name with a very depressed valuation.
Underwater positions on stocks you feel lukewarm about are prime candidates for tax selling.
It becomes difficult for me to tell you where to run in these markets...
Analyst downgrades and mind-boggling P/E ratios do not matter in this current market.
Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.
Buy Cardinal Health and give it time for the market to reassess the industry.
Micron Technology, Intel and Lam Research are good buys on this heat in semiconductors.
Relief is on the way, and there's an inexpensive beneficiary out in California.
This will be the ninth consecutive year when the big game tops that 100 million-viewers mark.
It's hard to understand the magnitude of the change.
They make more irrational, stupid moves based on nothing than I ever thought possible.
It might look easy now, but it looked easy in 1999, too.